Podcasts about Agonist

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog The newest miracle drug for weight loss is changing the lives of thousands of people who have battled obesity for extended periods of time….These GLP-1 medications are also treating or preventing the diseases that go with long term obesity: Diabetes, Heart Disease, Joint replacements, Arthritis, Sleep Apnea, and Alzheimer's Disease. Researchers are finding more indications every day for patients to take these weight loss medications. But like anything else there is no perfect answer to any problem.  Among the few side effects of this drug, the most frequent side effect is reflux, also called acid indigestion, or GERD (gastroesophageal reflux disease).  Often my patients don't even know what their diagnosis is, they just tell me about their symptoms. The symptoms of GERD include: Asthma symptoms A bad taste in the mouth Difficulty swallowing Dry, hacking, cough Chest pain after meals These symptoms are worse after a big meal, at bedtime, after spicy food, or dose related.  Most of my patients don't want to discontinue the GLP-1 inhibitors because they are finally losing weight!  We manage the GLP-1 side effect of GERD by decreasing dose of the medication and slowly increase the dose back to an effective level. We also offer lifestyle and dietary treatments before we offer prescription medication. Therefore, if reflux is not constant, and is not causing any lasting damage to the patient's esophagus, we can treat it with lifestyle changes and over the counter medication, to lower the stomach acid that is refluxing into the esophagus. The lifestyle changes patients can employ on their own are described below. Lifestyle changes needed to avoid or treat Gastric Reflux caused by GLP-1 agonists. What can you do to prevent and treat this side effect: Eat smaller meals: Large meals expand your stomach and put pressure on your lower esophageal sphincter (LES). Don't go to bed less than 2 hours after eating Avoid trigger foods see below Sleep on your left side Elevate the head of your bed Avoid tight clothing: Chew your food well– chew each bite for 20 seconds. Quit smoking: Smoking weakens your LES and makes your stomach more acidic. Stop drinking alcohol Chew (non-mint) sugar-free–gum  In addition to changing your active lifestyle, changing your diet is necessary as well. There are trigger foods to avoid minimizing your reflux symptoms.  tomato sauce and other tomato-based products high fat foods, such as fast food and greasy foods fried foods citrus fruit juices soda-diet and regular Caffeine Garlic onions mint of any kind milk based products My patients ask me, “So what can I eat?” …I admit I did take away some of the most exciting foods, however my patients ask me what they can eat so the list of foods that help avoid and treat GERD are listed below. High-fiber foods: vegetables, fruit, and whole grain bread. Alkaline foods. Foods fall somewhere along the pH scale (turns litmus paper blue). Drink alkalinized water (PH > 8) Ginger—fresh sushi Ginger from Asian food stores. Apple cider vinegar on salads and a Tablespoon in water every morning Lemon water—just squeeze a slice of lemon in your water. Coconut water Honey. Lean Protein including meat Low-Fat and Nonfat Dairy Products. Non-Citrus Fruits like apples, pears, bananas, and melons Vegetables like broccoli, Carrots, Corn, Cucumbers, Green Beans, Green peppers, Potatoes and Sweet potatoes   For my patients who take herbal and other supplements, the following is a list of the supplements that may decrease your symptoms of GERD. Chamomile Tea Licorice Marshmallow Slippery Elm Tablets Probiotics-Mega Brand Prebiotics-Mega Digestive Enzymes Aloe Vera Juice Baking Soda Magnesium glycinate What happens when you have made all the lifestyle changes you can and have lowered your GLP-1 dose or changed to a different type of GLP-1 Agonist, and you still have GERD? As a physician I prescribe medications to help my patients treat their GERD, however most of the medications have been placed over the counter so I can recommend them to my patients, and they can buy the medication without a script. The class of medication that treats GERD include Antacids, H2 Blocker, and Proton Pump Inhibitor.  Antacids neutralize stomach acid, but they typically only work for short periods. They are generally made of calcium. This type of medication is best used prn for symptom relief.  Side effects of antacids may include constipation and diarrhea. The second option for treatment of GERD is an H2 blocker. These drugs reduce the amount of acid the stomach releases. Eg. Pepcid, Tagamet, Gaviscon. Proton pump inhibitors (PPIs): These drugs are available by prescription from a healthcare provider, and now some doses are over the counter. PPIs help reduce the amount of acid the stomach makes.  They should be used for a two-week period only for severe attacks and then you should change to an H2 blocker or antacid. WHY stop a PPI after 2 weeks?   Omeprazole is an example of a PPI.  Theses medication kill the good bacteria in your intestines, change your breath and can affect how you absorb your nutrients. If you must take them chronically to treat and prevent the progression of damage to the esophagus. What if I did everything and GERD is still a problem: If your condition is severe, your doctor may recommend a consultation with a GI doctor for an endoscope or other diagnostic procedure.  In addition, you may have to hold your GLP-1 Agonist for a period of time while you treat your esophageal inflammation. Just as in all medical issues there are many ways to treat side effects of drugs. Your provider will prescribe the medication that she or he is most comfortable with. What next? So if you have reflux and are on a GLP-1 inhibitor, you may be advised to decrease your dose or switch to Tirzepatide medication (Mounjaro, Zepbound). There are many steps you can take before you need prescribed medication. Your doctor may even change your GLP-1 agonist prescription or refer you to a GI doctor, but before this is necessary you should try the lifestyle and dietary changes that I recommend in this Blog first. This side effect of GLP-1 agonists doesn't affect every patient and can be managed as you see above, however the lifestyle changes and dietary changes can only be done by you, so the ball is in your court!

Witam Państwa, nazywam się Jarosław Drożdż, pracuję w Centralnym Szpitalu Klinicznym Uniwersytetu Medycznego w Łodzi, skąd nagrywam podcast Kardio Know-How. W tym odcinku omawiam doniesienia z ACC 2025.Szczegółowy TRANSKRYPT do odcinka.Podcast jest przeznaczony wyłącznie dla osób z profesjonalnym wykształceniem medycznym.

Send us a textA debut album can be a defining moment for any band, but for seasoned vocalist Vicky Psarakis, it's just another challenge to take head-on. When we last spoke with Vicky in 2022, she was fronting melodic death metal outfit The Agonist while simultaneously developing her nu-metal side project, Sicksense. Following The Agonist's breakup, Vicky fully committed to Sicksense, proving that this may have been her true calling all along.Now, she returns to IUF to discuss Cross Me Twice, Sicksense's highly anticipated debut album—a bold fusion of modern metal and electronic elements that brings a fresh energy to the nu-metal resurgence. Despite lineup changes since the band's inception in 2021, Vicky has steered the group forward, solidifying their sound and vision. With over two decades in the industry, a Juno nomination, and an extensive list of guest vocal appearances, her journey is nothing short of inspiring. Tune in now as Vicky shares her story, and be sure to buy and stream Cross Me Twice, out now worldwide via Earache Records.Stay connected with Sicksense, visit: https://soundescapeagency.com/sicksense/, https://www.instagram.com/sickxsense/, and https://www.facebook.com/sickxsense/Stay connected with IUF, visit: https://interviewunderfire.com/

การกินถูกควบคุมอัตโนมัติ (แต่เรามักจะไม่เชื่อกันว่า เวลาเราสั่งผัดกะเพราเนื้อริบอายจากร้านนี้นั้น สมองส่วน hypothalamus เป็นผู้สั่ง เพราะมันคือ option generator ที่อยู่ตำแหน่งบนสุด เราไม่ได้สั่งมาจาก conscious brain) เหมือนความดันโลหิต ระดับน้ำตาลในเลือด อุณหภูมิร่างกาย มีระบบ feedback control ที่แน่นหนา เราจึงพบว่าการลดน้ำหนักที่ดูเหมือนง่าย เพราะก็แค่ควบคุมการกินเข้าให้เท่ากับการใช้ออกไป แต่กลับไม่ง่ายเพราะCalories in & Calories out are not independent มีระบบควบคุมน้ำหนักอยู่ที่ hypothalamus คอยปรับสมดุล CI และ CO อยู่เสมอ มีงานวิจัยสำคัญชื่อ Long-Term Persistence of Hormonal Adaptations to Weight Loss ตีพิมพ์ใน NEJM ในปี 2554 ที่อธิบาย biological feedback เมื่อเราลดน้ำหนัก ผ่านฮอร์โมนหิวและอิ่ม leptin เพื่อพาร่างกลับไปที่จุดตั้งค่าน้ำหนักเดิมตอนที่เราอ้วน เมื่อเราลดน้ำหนักไปสักพัก เราจะถึงจุดที่เรียกว่า weight plateau ลดน้ำหนักต่อไปไม่ได้อีกแล้ว และน้ำหนักกำลังจะคืบคลานกลับไปที่จุดตั้งค่าน้ำหนักเดิมตอนอ้วน นั่นหมายถึงผู้ที่ลดน้ำหนักกำลังต่อสู้กับ “Biology” ของตัวเอง ซึ่ง Dr.Stephan Guyenet ผู้เขียนหนังสือชื่อ “The Hungry Brain” กล่าวว่า “Biology always wins”

Vicky Psarakis joins the podcast to speak about the political state of the country following the 2024 US Presidential Election, and together we speak about how the goals of the American people are more aligned than many believe. Vicky, as evidenced by her lyricism in her newest project Sicksense, is no stranger to writing about the common goals and enemies that should be focused on in society, and I very much appreciated having her point of view and discussing how recent events tie into the lyrics of her past and present. Sicksense's new album "Cross Me Twice" is out now

We're back, after a brief hiatus! Today we talk about duration of therapy for bacteremia, Factor XI inhibition for atrial fibrillation, whether to stop ACEi or ARB before elective surgery, and whether GLP-1 agonists are beneficial in heart failure with preserved ejection fraction. Go to minute 7:30 to skip the banter. 7 vs 14 Days of Antibiotics for Bacteremia (BALANCE)Abelacimab vs Rivaroxaban for Atrial Fibrillation (AZALEA-TIMI-71)Asenduxian vs Apixaban for Atrial Fibrillation (OCEANIC-AF)ACEi or ARB Discontinuation Before Surgery (STOP or NOT)Tirzepatide for HFpEF and Obesity (SUMMIT)Music from Uppbeat (free for Creators!):https://uppbeat.io/t/soundroll/dopeLicense code: NP8HLP5WKGKXFW2R

The beatdown is back!! And right out of the gate we're bringing you RE-ANIMATOR to kick off season 2. That's right folks, ooey gooey practical effects, full frontal nudity, and the always lovely Barbara Crampton are here to help us ring in the new year! Find us online: Instagram: @bmoviebeatFacebook: The B Movie BeatdownEmail: thebmoviebeatdown@gmail.com Letterboxd: @Petedown @SlenderJames

Willkommen zum wöchentlichen Longevity Briefing! Jede Woche sprechen wir über die neuesten Entwicklungen in der Welt der Healthy Longevity. Wir bringen dir wissenschaftlich fundierte News, neue Therapien, spannende Forschungsergebnisse und vieles mehr. Diese Woche: 1. Das Gedächtnis unserer Fettzellen und wie sie den Jo-Jo-Effekt begünstigen könnten. Zum Blogartikel: https://stayoung.de/blog/Fettzellen_Gedaechtnis Zur Studie: https://www.nature.com/articles/s41586-024-08165-7 2. Demenzprävention: Fast die Hälfte der Demenz-Fälle wäre vermeidbar! Zum Blogartikel: https://stayoung.de/blog/Demenz_vermeidbar Zur Studie: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/abstract 3. Noch einmal Früherkennung: Es geht um Eierstockkrebs. Zum Blogartikel: https://stayoung.de/blog/Eierstockkrebs Zur Studie: https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-24-0393/750022/Early-Detection-of-Ovarian-Cancer-Using-Cell-Free

Simon McKay & I have a conversation about the end of The Agonist, filling in for other bands & his new solo project. Throughout this chat, Simon drank a Peach x Mango Kombucha while I enjoyed 5e Baron's "Two Tales Pils" the 5% Pilsner. This is a Heavy MTL presents Vox&Hops episode! Heavy MTL is Montreal's premier metal promoter. They host one of North America's best Metal Festivals & present countless amazing events during the rest of the year. I am truly honored & extremely excited to have them involved in the podcast. Make sure to check out Vox&Hops' Brewtal Awakenings Playlist which has been curated by the Metal Architect Jerry Monk himself on either Spotify or Apple Music. This playlist is packed with all the freshest, sickest & most extreme albums each week! Episode Links: Website: https://www.voxandhops.com/ Join The Vox&Hops Mailing List: http://eepurl.com/hpu9F1 Join The Vox&Hops Thirsty Thursday Gang: https://www.facebook.com/groups/162615188480022 Simon McKay: https://www.facebook.com/simon.mckay.129 5e Baron: https://www.5ebaron.com/ Vox&Hops Brewtal Awakenings Playlist: https://www.voxandhops.com/p/brewtal-awakenings-metal-playlist/ Heavy MTL: https://heavymontreal.com/ Sound Talent Media: https://soundtalentmedia.com/  Evergreen Podcasts: https://evergreenpodcasts.com/ SUPPORT THE PODCAST: Vox&Hops Metal Podcast Merchandise: https://www.indiemerchstore.com/collections/vendors?q=Vox%26Hops Use the Promo Code: VOXHOPS10 to save 10% off your entire purchase. Pitch Black North: https://www.pitchblacknorth.com/ Use the Promo Code: VOXHOPS15 to save 15% off your entire purchase. Heartbeat Hot Sauce: https://www.heartbeathotsauce.com/ Use the Promo Code: VOXHOPS15 to save 15% off your entire purchase.

"Can I Stop Ozempic / Zepbound After Successful Weight Loss? " Introduction Dr. Ali Novitsky, your favorite obesity medicine expert and fitness guru, welcomes listeners back for the conclusion of her third and final part of the GLP-1 series. She offers a deep dive into evidence-based information in a world often clouded by misinformation surrounding coming off of the GLP1 obesity meds. Main Topic: Can You Come Off a GLP-1 Agonist? One of the most frequent questions Dr. Novitsky receives is whether it's possible to discontinue a GLP-1 agonist after achieving weight loss success. Does starting this medication mean a lifelong commitment? The answer is nuanced, and today's discussion takes a closer look at the factors involved. Addressing the Fear Dr. Novitsky acknowledges the fear many people have about starting a GLP-1 agonist, particularly concerns over lifelong use and potential side effects such as gastroparesis, cancer risks, and pancreatitis. She also addresses the stigma associated with these medications, often dismissed as “the easy way out” or a “quick fix.” The Role of Medication Medication, she explains, is simply a tool to level the metabolic playing field. Those who benefit from GLP-1 agonists still put in considerable effort with nutrition, exercise, behavioral management, and emotional work. For some, lifelong use may be necessary, while others might be able to discontinue the medication over time. Obesity and Medication Dr. Novitsky reminds listeners that obesity is a disease influenced heavily by genetics. Despite over half of the U.S. population meeting the criteria for obesity, only 4% are treated with medication. Public perceptions, often shaped by media focus on celebrity usage, can perpetuate the false notion that these medications are just a "quick fix". Coming Off the Medication Dr. Novitsky explains that individuals who reach their target weight and sustain it for approximately a year may consider trialing off the medication. However, certain conditions, such as PCOS, may require ongoing low-dose use to maintain results. Timestamps: 00:00:00 - Main Topic Introduction: Can You Come Off GLP-1 Agonists?00:03:15 - Addressing Fear of Long-Term Use of GLP-1 Agonists00:04:09 - Medication as the Fourth Pillar in Weight Loss00:05:02 - Stigma and Shame Around Using GLP-1 Agonists00:06:16 - Obesity Statistics and Medication Access00:08:01 - Starting GLP-1 Agonists: Lifestyle and Dosage00:09:03 - Quality of Life Improvements on GLP-1 Agonists00:10:18 - Future of Obesity Medicine and Microdosing00:11:44 - Combining Lifestyle Changes with Medication00:13:08 - Titrating Down and Coming Off Medication00:14:57 - Maintaining Weight Loss After Stopping Medication00:16:32 - Individualized Approach to Medication Management00:20:00 - Encouraging Patients to Stay on Medication if Beneficial00:21:04 - Mental Health Benefits of GLP-1 AgonistsConclusion Resources: The Muscles & Mindset Beginner Strength Training Program - 12 months for only $199! ⁠⁠⁠⁠⁠⁠⁠Enroll TODAY⁠⁠⁠⁠⁠⁠⁠. Nutrition Training Program for Healthcare Professionals is enrolling now! You can ⁠⁠⁠⁠⁠⁠⁠learn more HERE⁠⁠⁠⁠⁠⁠⁠. Dr. Ali's Advanced Strength Training program is now available for exercises at a higher level. See the details ⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠. Transform® 9.0 enrollment is now open! Get started with your bonus content today. ⁠⁠⁠⁠⁠⁠⁠Learn more HERE⁠⁠⁠⁠⁠⁠⁠. Follow Dr. Ali Novitsky on ⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠ Subscribe to The Metabolism, Muscles, and Mindset Podcast on ⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠ *Ali Novitsky MD, this podcast, and podcast write-up are NOT providing medical advice. We do not recommend you start any exercise program without first consulting with your doctor!*

Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study 

This week Jenny is joined by fitness and sports medicine expert Dr. Christle Gueverra to explore and discuss the hot topic and stigma of Ozempic (GLP-1 Agonist medicine) for the inside scoop on the use, science and considerations about the drug. By now you've probably heard or seen a lot of publicity, good and bad, about this drug and Dr. Christle is here to get into what it is, what it does, why it exists and how it can help in weight loss and weight loss management. She shares her educated insights on the mechanism of action of the medicine, who is the ideal candidate for use or avoidance, the difference between the variable brands and doses, the benefits and harms and even gets into the pipeline for where this field of study is going.  Whenever you're ready, here are 3 ways to help you get a stronger body, faster results, and a responsive metabolism:Join our private BODY TRANSFORMATION group and connect with women levelling up their goals: It's our Facebook community where ambitious women learn to get leaner, get faster results, and achieve more energy – CLICK HEREWork directly with me and my team privately: If you'd like to work with me and my team to lose fat and build more lean muscle…fill out my questionnaire and tell me about your goals…I'll get right back to you CLICK HEREIf you're a Trainer/Nutritionist/Aspiring Coach… I'm getting a small group of new trainers together to show them how to add a new income stream into their business, CLICK HERE to apply and I'll get right back to you. If you enjoyed this episode, make sure and give us a five star rating  and leave us a review on iTunes, Podcast Addict, Podchaser and Castbox.Resources:STRONG Fitness MagazineSTRONG Fitness Magazine on IGTeam Strong GirlsCoach JVBFollow Jenny on social media:InstagramFacebookYouTube https://  DISCLAIMER: The opinions, beliefs, and viewpoints expressed by the hosts and guests on this podcast do not necessarily represent or reflect the official policy, opinions, beliefs, and viewpoints of Disenyo.co LLC and its employees.

In Episode 1109, Dr. Tyna Moore, Mark Bell, Nsima Inyang, and Andrew Zaragoza talk about pain management and the pros and cons of a GLP-1 Agonist like Ozempic Follow Dr. Tyna on IG: https://www.instagram.com/drtyna/ Official Power Project Website: https://powerproject.live Join The Power Project Discord: https://discord.gg/yYzthQX5qN Subscribe to the Power Project Clips Channel: https://youtube.com/channel/UC5Df31rlDXm0EJAcKsq1SUw Special perks for our listeners below!

In Episode 1109, Dr. Tyna Moore, Mark Bell, Nsima Inyang, and Andrew Zaragoza talk about pain management and the pros and cons of a GLP-1 Agonist like Ozempic Follow Dr. Tyna on IG: https://www.instagram.com/drtyna/   Official Power Project Website: https://powerproject.live Join The Power Project Discord: https://discord.gg/yYzthQX5qN Subscribe to the Power Project Clips Channel: https://youtube.com/channel/UC5Df31rlDXm0EJAcKsq1SUw   Special perks for our listeners below!  

Kamyar Ghabili, MD, discusses the AJR article by Nelson et al. identifying patterns of changes in CT-based body composition measures after initiation of semaglutide therapy. ARTICLE TITLE - Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on trends in glucagon-like peptide-1 receptor agonist social media posts using AI.

Today, you'll learn about a new groundbreaking bionic leg, the problem with first impressions, and new tech that can detect microplastics in water in milliseconds. Bionic Leg “Bionic leg makes walking quicker and easier for amputees, trial shows.” by Hannah Devlin. 2024. “5.6 Million++ Americans are Living with Limb Loss and Limb Difference: New Study Published.” Amputee Coalition. 2024. “Agonist-antagonist Myoneural Interface (AMI).” MIT Media Lab. N.D. “Continuous neural control of a bionic limb restores biomimetic gait after amputation.” by Hyungeun Song, et al. 2024. First Impressions “How first impressions can trap us into making suboptimal decisions.” by Eric W. Dolan. 2024. “Missing out by pursuing rewarding outcomes: Why initial biases can lead to persistent suboptimal choices.” by Chris Harris, et al. 2023. Nanoplastic Detection “Cutting-edge technology detects nanoplastics in water - instantly.” McGill. 2024. “Scientists find about a quarter million invisible nanoplastic particles in a liter of bottled water.” by Seth Borenstein. 2024. “Nanoplastics in Water: Artificial Intelligence-Assisted 4D Physicochemical Characterization and Rapid In Situ Detection.” by Zi Wang, et al. 2024. Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. Hosted on Acast. See acast.com/privacy for more information.

Drs. Sandeep K. Mallipattu and Bhaskar Das discuss the findings from their study, "A Small Molecule Agonist of Krüppel-Like Factor 15 in Proteinuric Kidney Disease," with JASN Deputy Editor Alessia Fornoni.

In this episode, we're uncovering some surprising side effects of GLP-1 agonists that you may not have heard about. While these medications have been celebrated for their effectiveness, emerging research is revealing a more nuanced picture of their impact on the body. We'll discuss what scientists are discovering, both the good and the unexpected, and what this means for you or anyone considering these medications. Plus, stick around as we explore the next frontier in this field: a new and potentially more impactful version of GLP-1 agonists that's making its way through the research pipeline. Could this be the next big thing in weight management and metabolic health? You won't want to miss it.Research Links:https://www.neurologylive.com/view/glp-1-agonist-liraglutide-shows-protective-effects-alzheimer-disease-phase-2-trialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525376/https://www.sciencedirect.com/science/article/pii/S221287782100020Xhttps://www.sciencedirect.com/science/article/abs/pii/S0028390818300406?via%3Dihub,https://www.nature.com/articles/s41598-023-48267-2https://www.acpjournals.org/doi/10.7326/M23-2718https://www.biopharmadive.com/news/pcos-glp-1-weight-loss-drugs-fertility/719872/West Wellness and Longevity LinksAre you ready to make change but don't know where to start. Book a free 30 min consultation here.https://www.westwellnessatx.com/get-startedAre you feeling rundown? Try this amazing Glutathione spray. Glutathione is a potent anti-oxidant that works hard to remove toxins from our bodies. Within minutes you will feel a boost of energy! https://aurowellness.com/?ref=983Can't afford to take the skinny shot? Try calocurb! This one of a kind supplement works like the skinny shot. It take the "food noise" away and allows you to focus on a clean Whole Foods diet, while stabilizing blood sugar levels! Use the code TARA10 and get 10% off your first order. https://www.calocurb.com?sca_ref=6404263.tgXaSY3HQx TARA10View all my favorite products that I personally use myself and in my practice here. https://www.westwellnessatx.com/productsiloveReady to take your health and longevity into your own hands. Order your own functional lab panels from my lab shop here: https://www.westwellnessatx.com/labshopHave questions? Feel free to reach out to me at: tarawest@westwellnessatx.com !

You've likely heard the headlines gushing about the weight loss effects of the GLP-1 agonist class of drugs, agents that go by names like Wegovy, Mounjaro, Rebelsus and others. Doctors are declaring these drugs as breakthroughs or even magical, witnessing the rapid and dramatic weight loss they can achieve. People appear willing to accept the side-effects of nausea, vomiting, even bowel obstruction, a catastrophic complication, or thyroid cancer, or pancreatitis that can irreversibly damage your pancreas and make you a type 1 diabetic. They also accept the costs that vary widely, depending on who dispenses it, but not uncommonly hundreds of dollars, even over a thousand dollars a month. And doctors jump at the chance to prescribe these drugs, as they often have arrangements with the dispensing pharmacy for kickbacks in one form or another. Prescribe the drug, make a lot of money, for many doctors an irresistible temptation. People lose weight and even can become non-type 2 diabetic and modestly reduce risk for heart disease—so what's not to like? Plenty. That is the topic of discussion today on the Defiant Health podcast, a place where you hear ideas you cannot hear anywhere else because we dig deeper, are not swayed by big payoffs, and thumb our nose at conventional wisdom. The GLP-1 agonist drugs are not miraculous, but invite health disaster or hold you hostage for the rest of your life, shelling out money to enrich the pharmaceutical industry and doctors.________________________________________________________________________________For BiotiQuest probiotics including Sugar Shift, go here.A 15% discount is available for Defiant Health podcast listeners by entering discount code UNDOC15 (case-sensitive) at checkout.*_________________________________________________________________________________Get your 15% Paleovalley discount on fermented grass-fed beef sticks, Bone Broth Collagen, low-carb snack bars and other high-quality organic foods here.* For 12% off every order of grass-fed and pasture-raised meats from Wild Pastures, go here.Support the Show.Books: Super Gut: The 4-Week Plan to Reprogram Your Microbiome, Restore Health, and Lose Weight Wheat Belly: Lose the Wheat, Lose the Weight and Find Your Path Back to Health; revised & expanded ed

Show Notes: On today's episode of the podcast, we dive into the truth behind Ozempic, a GLP-1 agonist. Ozempic mimics glucagon-like peptide 1 (GLP-1), a naturally occurring hormone released by the gut after eating. This hormone prompts the pancreas to produce insulin, helping to control blood sugar levels. GLP-1 Agonists treat type II diabetes, however Ozempic is one of the brand name GLP-1 Agonist medications that is now being prescribed for weight loss treatment. First we discuss what Ozempic is and what peptides are. We further discuss the pros and cons of taking ozempic by diving into the research. Research on GLP-1 Agonists for weight loss is limited to short term studies, however, we share why we think GLP-1 Agonists are probably pretty safe for the body long term. However, because of the nature of these medications, we discuss why it is extremely important to continue to strength train and get your daily protein amount in while taking this medication. We finish this episode with our opinions about the future of fitness and why GLP-1 Agonists can potentially lead to ethical dilemmas for individuals.  We partner with registered dietitians to offer nutrition coaching. One of our dietitians wrote an interesting blog on how to increase your GLP-1 naturally.In this episode we discuss:Benefits of OzempicReasons to take OzempicWhy you need to strength train while on Ozempic Side Effects and ConsiderationsFinancial and Health Care Considerations

Dr. Christle Guevarra returns to share some insight into her presentation at our Evolve Strength Business and Coaching Conference, Sept 13-14 in Edmonton, Alberta. Christle shares: -Deeper insights into GLP-1 Agonist drugs like Ozempic and tackles some of the common misconceptions and online arguments against using the drug, including suggestions that it's somehow "cheating" -Why resistance training is important with Ozempic -Plus some insights into what Christle is doing in her career --- Support this podcast: https://podcasters.spotify.com/pod/show/thefitnessdevil/support

After the boom in usage of weight loss inhibitors last year by the likes of Ozempic, Wegovy, Mounjaro and more, it's time to take a step back and look at how these new medications have changed our healthcare landscape.Personal Trainer Brendan Copley, CSCS, ATC, and Nutritionist Ashley Jerry, MS, tackle the important questions of who should be taking these GLP-1 Agonist medications, concerns to watch out for, what to think about when coming and off the medication, and finally, what other healthy habits should be incorporated into the process to ensure clients stay healthy and achieve the results they were looking for.

As I discuss the issues of GLP-1 agonist and GLP-1/GIP co-agonist weight loss drugs Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)I've been increasingly hearing from people who are engaged in practices with these drugs that are not remotely evidence based. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

This is the second part of our conversation with Dr. Yunus Tuncel on philosophical approaches to emotions in sports. We explore how Kierkegaard's and Heidegger's accounts of anxiety can be applied to think of risk sports, discuss violence and aggression, and finish up on how to care for emotions in sports from a more practical perspective. Our conversation draws heavily on Yunus's book Emotion in Sports: Philosophical Perspectives. Dr Yunus Tuncel teaches Philosophy at The New School, New York, and in New York University's Liberal Studies Programme. He is a co-founder of the Nietzsche Circle and a member of the Editorial Board of its journal The Agonist. Yunus is also the founder of Philomobile, which is a travel organization offering trips to those interested in studying philosophy on the road (Philomobile – Explore and Study Philosophy).  

In this episode, we explore emotions in sports from a philosophical perspective. How are philosophical perspectives different from the more established psychological perspectives? How can ideas found in Aristotle, Nietzsche, Hume, and Spinoza help us establish a framework to explore emotions in sports? Why are certain emotions and their balance essential for sustaining our sporting culture as we know it today, or could we find a better emotional balance in our individual and collective sporting lives? Our conversation draws heavily on Yunus's book Emotion in Sports: Philosophical Perspectives. Dr. Yunus Tuncel teaches Philosophy at The New School, New York, and in New York University's Liberal Studies Programme. He is a co-founder of the Nietzsche Circle and a member of the Editorial Board of its journal The Agonist. Yunus is also the founder of Philomobile, which is a travel organisation offering trips to those interested in studying philosophy on the road (http://www.philomobile.com/). The conversation continues in Part 2 with a focus on more specific emotions such as anxiety, fear, anger, and joy in sport. --- Found the episode interesting? Our previous conversation with Yunus can be found here: Part 1, Part 2. Related conversation on risk sports and authentic existence with Prof. Gunnar Breivik is here.  

Udith Dematagoda, editor of Hyperidean Press and author of the stellar new novel Agonist, joins Adam and Matt to discuss his home country of Scotland's greatest cultural export: Trainspotting and Trainspotting 2FULL EPISODELINKS Buy Udith's novel Agonist Follow Udith on SubstackThe cast of Trainspotting reunites

Sean Solo Show for you to live Optimal.  In today's episode we're covering GLP-1 Agonist Drugs This is not medical advice. I am not a doctor. My opinions should not be taken as medical advice.  Find OPP episodes, discounts on products, learn about my Life Coaching and Performance Coaching work at Seanmccormick.com  - send me an email and schedule a free 45 minute coaching strategy session sean@seanmccormick.com EPISODE SPONSORS - BioProtien+ - Boost HGH Naturally - Get $30 off here code OPP

Nausea is one of the most frequently reported side effects of GLP-1 agonist medications used in obesity treatment, such as Zepbound, Wegovy, Mounjaro, and Victoza. Although not everyone will experience it, the nature of these anti-obesity medications can often lead to nausea, caused by the slowing of gastric emptying.Anyone who has experienced nausea before, especially during pregnancies, will understand just how debilitating it can be, impacting your daily life and work. So, what level of nausea should you expect from weight loss medications? And how can we effectively manage this side effect? In this episode, I'm sharing practical strategies to mitigate nausea, advice on when to seek medical advice, and insights on using medications like Zofran to ease discomfort.Remember: This podcast provides general educational information. Always consult your doctor and medical team for personalized advice and guidance on any symptoms you're experiencing.ReferencesQuest Nutrition Cheese CrackersDevotion Nutrition HydroFLEX PacketsGHOST®Audio Stamps00:58 - Dr. Rentea explains why most anti-obesity medications contribute in some capacity to nausea and describes the nature and impact of this common side effect.06:05 - Dr. Rentea encourages us to be mindful of the types of foods consumed while on anti-obesity medications as certain foods can trigger nausea more than others.08:20 - We hear the importance of hydration in managing nausea and Dr. Rentea explains how cold drinks and electrolyte products can alleviate symptoms.13:05 - Dr. Rentea shares some general tips and changes you can make to your diet to help manage nausea.17:35 - Dr. Rentea stresses that vomiting is not normal and urges consulting a doctor if it occurs, as adjustments to eating habits or medication dosage may be necessary.Quotes“You need to be spacing out your food because most people will not be able to eat these bigger meals at once.” - Matthea Rentea MD“If you are avoiding fried stuff, greasy, or really high sugar foods, it's going to be really helpful.” - Matthea Rentea MD“Vomiting is never normal. You always need to talk to your doctor.” - Matthea Rentea MD“Electrolytes can oftentimes be helpful for nausea and headaches.” - Matthea Rentea MD“Something like Zofran, if you're not allergic, is just nice to have in your toolkit. But you need your physician to walk you through when and how to use it.” - Matthea Rentea MDAll of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com

Udith is very patient with our enthusiastic young intern Nathan Schmidt as he reviews his fantastic new book the Agonist! if you take one thing away from this. The book rules and you should buy it go to Hyperidean press' website and check it out.

in this episode, we discuss the role of various receptors and describe the terms - partial agonist, antagonist, and inverse agonists.

Join me, Dr. Mike T Nelson, as we explore the fascinating world of GLP-1 agonists like Wegovy with diabetes education expert Christa Rymal. We discuss the nuances of these weight loss drugs, their benefits, and potential drawbacks, especially in relation to diabetes management and off-label uses.Christa's insights provide a deeper understanding of how these medications work beyond glucose control, their impact on appetite, and the critical need for monitoring in prescribed use. We also contemplate the future of health and wellness models that might integrate these drugs and the significant role fitness professionals can play in this evolving landscape.Sponsors:Tecton exogenous ketone drink: https://tectonlife.com/ DRMIKE to save 20%Flex Diet Certification - sign up to be notified when the course opens.Episode Chapters:(0:00:00) - Weight Loss Drugs(0:11:18) - Impact of GLP-1s on Health(0:20:51) - The Impact of Obesity and Medication(0:34:18) - Mitigating Lean Muscle Mass Loss(0:46:25) - Challenges of Healthy Habits in Society(0:50:40) - Weight Loss With GLP-1 and Lifestyle(0:59:41) - Exploring Weight Loss Alternatives and Strategies(1:07:07) - The Power of Movement in Health(1:10:45) - Aging, Health, and Longevity DiscussionEpisodes You May Enjoy:Episode 209: How to achieve your fat loss goals while not overly restrictive: an interview with the author of "You Can't Screw This Up," Adam Bornstein.Episode 173: High-Level Nutrition and Programming for Fat Loss: Dr. Pat Davidson with Dr. Mike T NelsonFind Christa:InstagramThe Points RetreatGet In Touch:Instagram: https://www.instagram.com/drmiketnelson/YouTube: https://www.youtube.com/channel/UCn1aTbQqHglfNrENPm0GTpgEmail: https://miketnelson.com/contact-us/

We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.

Dán cumtha ag Seán Ó Lúing in ómós do Kruger.

In the last 15 years, the landscape of diabetes and obesity management has been significantly transformed by the advent of GLP-1 receptor agonists which are about to become the most successful drugs in the history of medicine, eclipsing drugs like insulin and statin. Dr Alain Bouchard, MD discusses with Dr. Timothy Garvey, Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham. 

Use of second-line noninsulin diabetic medications, like Glucagon-like peptide 1 (GLP-1) agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors, is rapidly increasing for treatment of T2D and other indications. As these drugs are being used by an increasing group of fertile women, it is expected that a few of them will get pregnant and data on their safety when used in the first trimester is needed. Is periconceptional use of glucagon-like peptide 1 (GLP-1) receptor agonists associated with increased risk of major congenital malformations? In this episode, we will look at the available data (although limited) regarding these medications, focusing on specific GLP1 options.

Understanding the benefits and drawbacks of Ozempic is crucial when considering how to manage your weight after stopping this medication. As a GLP-1 Agonist, Ozempic mimics a hormone in your small intestine that helps regulate insulin levels, control appetite, and slow down gastric emptying. While this can aid in weight loss, it can also lead to adverse side effects. These side effects may include: • Nutrient deficiency • Gastroparesis • Constipation • Gallbladder problems • Thyroid tumors and cancer To help maintain your weight after Ozempic, it's crucial to make certain lifestyle changes, such as: 1. Follow a ketogenic diet to keep insulin levels low and promote fat-burning. 2. Do intermittent fasting to control appetite and improve hormone balance. 3. Incorporate weight training to build and preserve muscle mass. Additionally, ensuring adequate protein intake is crucial for maintaining muscle mass, especially for those who have already lost a significant amount of muscle while on Ozempic. This can be achieved through consuming bioavailable proteins such as red meat, eggs, and fish. Monitoring your hormone levels and ensuring proper cholesterol intake is also important, as cholesterol is a building block for many hormones, including testosterone and estrogen.

Welcome to the next installment of the Anesthesia Patient Safety podcast hosted by Alli Bechtel.  This podcast is an exciting journey towards improved anesthesia patient safety.We are returning to the conversation about GLP-1 receptor agonist medications today and listening to episodes #160 and #161 again. Patients taking these medications may be at increased risk for aspiration even after an appropriate preoperative fasting period. Tune in today as we talk about how to keep patients taking GLP-1 receptor agonists safe during anesthesia care.Additional sound effects from: Zapsplat.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/189-glp-1-receptor-agonist-recommendations-revisited/© 2024, The Anesthesia Patient Safety Foundation

I recently came across a short article in Nature (one of the leading scientific journals) about some increasingly convincing evidence of anti-inflammatory effects of the GLP-1 Agonists. You know these by the name of Trulicity, Weegovy, Mounjaro or Zepbound. In addition to helping with diabetes and obesity, we are finding that they have their own anti-inflammatory effects. Should we use them in inflammatory arthritis?Read the article from Nature: https://www.nature.com/articles/d41586-024-00118-4Remember to hit the like button, share with anyone you think might find it helpful, and subscribe to our channel for more health-related videos. Thanks for helping us grow!Are you, or someone you love, looking for a rheumatologist near you? Maybe you queried Google for the “best rheumatologist in Denver” and felt that no other arthritis clinic in Denver really seemed personable? Or maybe you are simply looking for a doctor who will listen to you and work with you to achieve disease remission? Well, you have come to the right place. UnabridgedMD has the best rheumatologist in Denver, Colorado and we cannot wait to work with you. Click here to get in touch https://www.unabridgedmd.com or call 303-731-4006#health #rheumatologist #autoimmunedisease #denverIf you live in Colorado and are looking for a rheumatologist to help you achieve disease remission, email or contact us at UnabridgedMD.com. We are the first direct care rheumatology in Colorado and can see you within a week!

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net. Today on the emDOCs cast with Jess Pelletier and Brit Long, we discuss the GLP-1 agonist craze, complications, and medication compounding. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play

On the days when I need some hope and good news, I think about Medical Students for Size Inclusivity. In their own words “We are a community of medical students raising awareness about the harms of weight discrimination in the healthcare system. We believe all people, regardless of their weight, body shape, and size, deserve equitable medical treatment and the right to pursue health".They do incredible work, including the GLP-1 Agonist informed consent project that I've linked to here before.The fact that these incredible people are the future of medicine gives me more hope than I can say.Today in our “5 questions with…” series we have 5 questions with three amazing MSSI members! Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

We talk about research articles and hot topics. A special report came out focusing on the GLP-1 Agonist plateau which no one is talking about. Patients who are taking semaglutide injections such as Ozempic and Wegovy are hitting a plateau after months of losing weight. This is not a surprise to physicians but patients are surprised.

While breakthrough drugs Ozempic and Mounjaro have been celebrated as weight loss miracles, many of their users report severe side effects like hair loss, paralysis, and – according to a recent lawsuit – “projectile vomiting unlike anything I've ever experienced.” “Oddly, steak doesn't paralyze the stomach!” Dr. Shawn Baker tweeted in response. Is an almost-all meat diet a safer and healthier weight-loss alternative? Can modern “bug protein” burgers compare to the nutrition found in real meat? Dr. Baker discusses LIVE and joins Dr. Drew to answer your calls. Dr. Shawn Baker is an orthopedic surgeon, bestselling author of “The Carnivore Diet” and a cofounder of Revero. He is widely known as a leading authority on treating disease through medical nutritional therapy. Follow him at https://x.com/SBakerMD and learn more about the carnivore diet at https://carnivore.diet/ 「 SPONSORED BY 」 Find out more about the companies that make this show possible and get special discounts on amazing products at https://drdrew.com/sponsors • PROVIA - Dreading premature hair thinning or hair loss? Provia uses a safe, natural ingredient (Procapil) to effectively target the three main causes of premature hair thinning and hair loss. Susan loves it! Get an extra discount at https://proviahair.com/drew • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • GENUCEL - Using a proprietary base formulated by a pharmacist, Genucel has created skincare that can dramatically improve the appearance of facial redness and under-eye puffiness. Get an extra discount with promo code DREW at https://genucel.com/drew • COZY EARTH - Susan and Drew love Cozy Earth's sheets & clothing made with super-soft viscose from bamboo! Use code DREW for a huge discount at https://drdrew.com/cozy • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your personal physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. 「 ABOUT DR. DREW 」 Dr. Drew is a board-certified physician with over 35 years of national radio, NYT bestselling books, and countless TV shows bearing his name. He's known for Celebrity Rehab (VH1), Teen Mom OG (MTV), The Masked Singer (FOX), multiple hit podcasts, and the iconic Loveline radio show. Dr. Drew Pinsky received his undergraduate degree from Amherst College and his M.D. from the University of Southern California, School of Medicine. Read more at https://drdrew.com/about Learn more about your ad choices. Visit megaphone.fm/adchoices

During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate.In this episode, Kris V. Kowdley MD, FAASLD, FACP, FACG, discusses topline results from several of these studies and more, including: A combination of 3 studies—HEROES, COBALT, and COBALT EC—that evaluated the real-world effectiveness and safety of second-line therapy in PBC where OCA was added to the treatment regimen of people with PBC with an incomplete response to ursodeoxycholic acid Lessons learned from a long-term outcomes study of people with PBCResults from 2 phase II studies of obeticholic acid plus bezafibrate in people with PBC who did not respond to or were intolerant of ursodeoxycholic acidPresenter:Kris V. Kowdley MD, FAASLD, FACP, FACGProfessor, Elson S. Floyd College of MedicineWashington State UniversityDirector, Liver Institute NorthwestSeattle, Washington      Link to reviews of other PBC studies from AASLD 2023: https://bit.ly/3RvXXEI

During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate.In this episode, Stuart C. Gordon, MD, FAASLD, discusses topline results from one of these late-breaking studies and more, including: A phase III study of an investigational PPAR-delta agonist (seladelpar) in people with PBC who had failed to respond to ursodeoxycholic acidA study that explored racial differences as they relate to the presentation and diagnosis of PBCPresenter: Stuart C. Gordon, MD, FAASLDDirector of HepatologyHenry Ford Health SystemProfessor of MedicineWayne State University School of MedicineDetroit, MichiganLink to commentary:https://bit.ly/3GzRMt2Link to reviews of other PBC studies from AASLD 2023:https://bit.ly/3RvXXEI

During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate.In this episode, Marlyn J. Mayo, MD, discusses topline results from several of these studies and more, including: A phase III study of an investigational dual PPAR α/δ agonist (elafibranor) in people with PBC who did not respond to or were intolerant of ursodeoxycholic acid (UDCA)A study that evaluated the effectiveness and safety of second-line therapy in PBC where obeticholic acid with or without a fibrate was added to the treatment regimen of people with PBC with an incomplete response to UDCAA retrospective review of the rates of hyperlipidemia, atherosclerosis, and/or hepatic steatosis in patients with PBCPresenter: Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasLink to commentary:https://bit.ly/47PmGdcLink to reviews of other PBC studies from AASLD 2023: https://bit.ly/3RvXXEI

As we enter our last month of Nutrition Radio Season Two, exercise physiology and biology double major Abbie Stack joins the show. This time we cover: 1.) Food Trend: Faux Fish  2.) Breaking Science: How Much Nutrition Training Do Doctors Get? 3.) Weight Management Tip: Yerba Mate Tea - A GLP-1 Agonist? 4.) Recipe: Sour Patch "Kid Grapes" --------- NEW! Donate to the show: https://www.paypal.com/donate/?hosted_button_id=3J6ZFPPKG6E6N NEW! Subscribe to newsletter:  https://lp.constantcontactpages.com/su/VZMtIVF/podcastsignup Subscribe at Apple iTunes: https://podcasts.apple.com/us/podcast/nutritionradio-org/id1688282387  Podcast on Spotify: https://open.spotify.com/show/1ECHrnjxjn33DBNWgErPtp Subscribe to our YouTube backup: https://www.youtube.com/lonman07?sub_confirmation=1 Podcast on Amazon/ Audible: https://www.audible.com/pd/NutritionRadioorg-Podcast/B0BS8LFLLX?qid=1675812257&sr=1-1&ref=a_search_c3_lProduct_1_1&pf_rd_p=83218cca-c308-412f-bfcf-90198b687a2f&pf_rd_r=YKEZ8DX192TQF0CQV8KX&pageLoadId=u3x6bJ1 Podcast web site: https://sites.libsyn.com/455769/site Sister site: https://www.ironradio.org/ 

MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discuss how a Medicare switch led to a massive surprise medical bill, the GLP-1 agonist plateau no one's talking about, and a new position statement on Grateful Patient Fundraising. Episode produced and hosted by Rachael Robertson. Sound engineering by Greg Laub. Reporting by Cheryl Clark, Sophie Putka, and Michael DePeau-Wilson.

Commentary by Dr. Valentin Fuster

Vicky Psarakis & Robby J. Fonts of Sicksense & I have a conversation about launching the band in Montreal, Nu Metal, the birth of Sicksense, how they write songs, the best / worst parts of being in a band with your spouse, the end of The Agonist, mental health and how they fight the hops. Throughout this chat, Vicky drank L'Amère à Boire's "Drak" the 5.8% Polotmavy Pivo, Robby drank their "Müesli" the 5% Oatmeal Stout while I enjoyed their Černá the 5% Bohemian Pilsner. This is a Heavy MTL presents Vox&Hops episode! Heavy MTL is Montreal's premier metal promoter. They host one of North America's best Metal Festivals & present countless amazing events during the rest of the year. I am truly honored & extremely excited to have them involved in the podcast. Make sure to check out Vox&Hops' Brewtal Awakenings Playlist which has been curated by the Metal Architect Jerry Monk himself on either Spotify or Apple Music. This playlist is packed with all the freshest, sickest & most extreme albums each week! Photo Credit: Daniel Carne Episode Links: Website: https://www.voxandhops.com/ Join The Vox&Hops Mailing List: http://eepurl.com/hpu9F1 Join The Vox&Hops Thirsty Thursday Gang: https://www.facebook.com/groups/162615188480022 Sicksense: https://soundescapeagency.com/sicksense/ L'Amère à Boire: https://amereaboire.com/ Vox&Hops Brewtal Awakenings Playlist: https://www.voxandhops.com/p/brewtal-awakenings-metal-playlist/ Heavy MTL: https://heavymontreal.com/ Sound Talent Media: https://soundtalentmedia.com/  Evergreen Podcasts: https://evergreenpodcasts.com/ SUPPORT THE PODCAST: Vox&Hops Metal Podcast Merchandise: https://www.indiemerchstore.com/collections/vendors?q=Vox%26Hops Use the Promo Code: VOXHOPS10 to save 10% off your entire purchase. Pitch Black North: https://www.pitchblacknorth.com/ Use the Promo Code: VOXHOPS15 to save 15% off your entire purchase. Heartbeat Hot Sauce: https://www.heartbeathotsauce.com/ Use the Promo Code: VOXHOPS15 to save 15% off your entire purchase.